Chrome Extension
WeChat Mini Program
Use on ChatGLM

Interim Analysis of Key Clinical Outcomes from a Phase 1/2 Study of Weekly Intravenous DNL310 (Brain-Penetrant Enzyme Replacement Therapy) in MPS II

Molecular Genetics and Metabolism(2024)

Cited 0|Views24
Key words
Mucopolysaccharidoses,Enzyme Replacement Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined